Prostate cancer: diagnosis and management : guidance (NG131)

Source:
National Institute for Health and Care Excellence - NICE
Publication date:
09 May 2019

Abstract

This guideline covers the diagnosis and management of prostate cancer in secondary care, including information on the best way to diagnose and identify different stages of the disease, and how to manage adverse effects of treatment. It also includes recommendations on follow-up in primary care for people diagnosed with prostate cancer.

Recommendations

This guideline includes new and updated recommendations on:

It also includes recommendations on:

Who is it for?

  • Healthcare professionals
  • Commissioners and providers of prostate cancer services
  • People with prostate cancer, their families and carers

Guideline development process

How we develop NICE guidelines

This guideline updates and replaces NICE guideline CG175 (January 2014) and NICE diagnostics guidance 17 (June 2015).